Literature DB >> 19867447

THE BACTERIOLOGY OF SPUTUM IN COMMON NON-TUBERCULOUS INFECTIONS OF THE UPPER AND LOWER RESPIRATORY TRACTS, WITH SPECIAL REFERENCE TO LOBAR AND BRONCHO-PNEUMONIA.

T W Hastings1, W L Niles.   

Abstract

1. In our examinations, only 38 per cent. of the infections of the respiratory tract below the glottis were pure, and this percentage was reached only by carefully following Kitasato's method of handling sputa. 2. Lobar pneumonia may produce sputum free from pneumococci, and may undoubtedly be caused by organisms other than thepneumococcus. 3. There is found a marked yearly variation in the organisms which excite inflammation of the respiratory tract. 4. Micrococcus catarrhalis is usually considered a common secondary invader; but it may, and probably frequently does, assume pathogenic properties.

Entities:  

Year:  1911        PMID: 19867447      PMCID: PMC2124878          DOI: 10.1084/jem.13.6.638

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  1 in total

1.  Micro-organisms in the Healthy Nose.

Authors:  C Thomson; R T Hewlett
Journal:  Med Chir Trans       Date:  1895
  1 in total
  4 in total

1.  Blood Cultures Versus Respiratory Cultures: 2 Different Views of Pneumonia.

Authors:  Sarah Haessler; Peter K Lindenauer; Marya D Zilberberg; Peter B Imrey; Pei-Chun Yu; Tom Higgins; Abhishek Deshpande; Michael B Rothberg
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

Review 2.  Persistent and Recurrent Bacterial Bronchitis-A Paradigm Shift in Our Understanding of Chronic Respiratory Disease.

Authors:  Alya Ishak; Mark L Everard
Journal:  Front Pediatr       Date:  2017-02-15       Impact factor: 3.418

3.  A STUDY OF CULTURES FROM SPUTUM AND BLOOD IN LOBAR PNEUMONIA.

Authors:  T W Hastings; E Boehm
Journal:  J Exp Med       Date:  1913-03-01       Impact factor: 14.307

4.  Atypical pneumonia--time to breathe new life into a useful term?

Authors:  David R Murdoch; Stephen T Chambers
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.